相关实验视频

Updated: Jun 9, 2025

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
08:53

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

Published on: January 1, 2017

9.2K

基于FDA不良事件报告系统数据库的真实数据,挖掘和分析alendronate的不良事件信号

Ziyi Zhao1, Hongxiang Ji2, Chenghao Zhang1

  • 1Department of Hand and Foot, Microsurgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

Expert opinion on drug safety
|October 22, 2024
PubMed
概括

这项研究使用FDA数据确定了新的阿伦德罗纳特不良事件 (AE),揭示了骨折和血管问题等潜在风险. 需要进一步的研究来证实这些阿伦德罗纳特的副作用.

关键词:
艾伦德罗纳酸是一种酸盐.公平的人是公平的.不良事件不良事件不良事件数据挖掘是数据挖掘的一个方法.药物监督和药物监督

更多相关视频

Using Alizarin Red Staining to Detect Chemically Induced Bone Loss in Zebrafish Larvae05:03

Using Alizarin Red Staining to Detect Chemically Induced Bone Loss in Zebrafish Larvae

Published on: December 28, 2021

4.6K
Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

3.5K

相关概念视频

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67